Rheonix announced that it has received expanded FDA emergency use authorization for its Rheonix COVID-19 MDx assay. Ithaca, N.Y.-based Rheonix’s expanded authorization allows the use of saliva as an approved sample type after the assay was initially authorized for use on a range of respiratory specimens in April, according to a news release. The Rheonix […]